Routine annual meeting filing with no earnings or operational updates. The 5M share increase to the equity plan is standard practice and not immediately dilutive. No trading action warranted.
Price Chart
Executive Summary
NeoGenomics held its 2026 annual meeting on May 21, 2026, with 89.61% of outstanding shares represented. Stockholders approved all four proposals, including the re-election of nine directors, advisory approval of executive compensation, ratification of Deloitte & Touche as auditor, and an amendment to the 2023 Equity Incentive Plan to increase authorized shares by 5,000,000. This is a routine governance filing with no material financial impact.
Key Facts
- Annual meeting held May 21, 2026 with 116,630,120 shares represented (~89.61% of outstanding voting stock)
- Stockholders approved amendment to 2023 Equity Incentive Plan, increasing authorized shares by 5,000,000 (97.90% of votes cast in favor)
- All nine director nominees elected; advisory say-on-pay approved with 83.19% of votes cast in favor
- Ratification of Deloitte & Touche LLP as independent auditor approved with 99.57% of votes cast in favor
- No officer departures, no unexpected changes, no financial results disclosed
Financial Impact
No financial impact — routine governance and equity plan amendment with 5,000,000 additional shares authorized for future issuance
Risk Factors
- Potential future dilution from additional shares authorized under the equity plan, but no immediate issuance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-037735 |
| Document: 0001628280-26-037735-index-headers.html | 0001628280-26-037735 |
| Document: 0001628280-26-037735-index.html | 0001628280-26-037735 |
| Document: 0001628280-26-037735.txt | 0001628280-26-037735 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 21d ago | 8-K | $16.51 | awaiting T+60 | — | $17.42 (+5.57%) |
Jul 20, 2026 14w ago | 8-K | $14.45 $16.66 | ▲ +15.29% | ▲ +11.32% | $17.42 (+20.59%) |
May 22, 2026 22w ago | 8-K | $9.27 $16.66 | ▲ +79.67% | ▲ +76.94% | $17.42 (+87.97%) |
Apr 28, 2026 25w ago | 8-K | $8.96 $13.89 | ▲ +55.02% | ▲ +50.91% | $17.42 (+94.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers